{"id":"W2007390314","doi":"10.1016/s1474-4422(11)70012-6","title":"Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial","year":2011,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":195,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"ACADIA Pharmaceuticals; Ministero dell’Istruzione, dell’Università e della Ricerca; National Parkinson Foundation; Novartis; Genzyme; National Institute of Mental Health; Schering-Plough","keywords":"Parkinson's disease; Double blind; Physical medicine and rehabilitation; Medicine; Phase (matter); Physical therapy; Disease; Internal medicine; Physics; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001731078,0.00284626,0.006095034,0.0005949172,0.000620558,0.001431749,0.001350267,0.003220088,0.008960683],"category_scores_gemma":[0.002078121,0.001062143,0.002618443,0.0005888254,0.001797821,0.00205064,0.0006070553,0.004156074,0.001669334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008456091,"about_ca_system_score_gemma":0.001181119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001379389,"about_ca_topic_score_gemma":0.002488063,"domain_scores_codex":[0.9991915,0.0003940471,0.00005998782,0.0001764799,0.00004395517,0.0001340379],"domain_scores_gemma":[0.9990885,0.0003083043,0.0001660082,0.00007206108,0.00005894857,0.0003061578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9922115,0.000898402,0.0001093868,0.0006066276,0.0006015314,0.0000297465,0.00002442432,0.0001258075,0.0007456535,0.00009749355,0.0004010205,0.004148418],"study_design_scores_gemma":[0.9879133,0.01115339,0.0002349134,0.00002186487,0.0001820438,0.00001472391,0.00001013174,0.0001039418,0.00006130805,0.0001058765,0.0001897684,0.000008700905],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9636517,0.01701417,0.002556424,0.001976312,0.002779825,0.005944742,0.002277976,0.0004376989,0.003361141],"genre_scores_gemma":[0.9689015,0.008714767,0.003167263,0.002677832,0.001150937,0.007108774,0.001845234,0.00007490938,0.006358745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008960683,"threshold_uncertainty_score":0.02997649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03210741335143601,"score_gpt":0.2631726952557821,"score_spread":0.2310652819043461,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}